Relaxing the promotional shackles – PR Week Post #16
August 6, 2009
An article in Pulse online today (http://www.pulsetoday.co.uk/story.asp?sectioncode=23&storycode=4123410&c=1) talks about the potential “loosening of restrictions on drug companies” which may facilitate them to deliver more information “directly to patients through online and print publications.” This ongoing debate is sure to continue ad nauseam without ever reaching a satisfactory conclusion.
Is the industry’s “conflict of interest” that acute? Are there circumstances where patients might actually benefit?
Raise your hand if you have never visited a US pharmaceutical product website and clicked on the box entitled ‘I am a US resident’ to gain access to the information. Surely we are not talking about unregulated communication over the internet so why all the hysteria?